Canada markets closed

BioForce Nanosciences Holdings, Inc. (BFNH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.5000+0.0800 (+5.63%)
At close: 02:41PM EDT

BioForce Nanosciences Holdings, Inc.

2020 General Booth Boulevard
Suite 230
Virginia Beach, VA 23454
United States
757 306 6090
https://www.bioforceeclipse.com

Sector(s)Consumer Defensive
IndustryPackaged Foods
Full Time Employees3

Key Executives

NameTitlePayExercisedYear Born
Mr. Aleksandr ShapiroPresidentN/AN/A1960
Mr. Steven GagnonCo-Chief Executive OfficerN/AN/A1962
Mr. John LaVioletteCo-Chief Executive OfficerN/AN/A1961
Mr. Richard KaiserCFO, Corporate Secretary, Corporate Governance Officer, Principal Accounting Officer & DirectorN/AN/A1966
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online under the BioForce Eclipse brand, as well as through social media and telemarketing. BioForce Nanosciences Holdings, Inc. was incorporated in 1999 and is based in Virginia Beach, Virginia.

Corporate Governance

BioForce Nanosciences Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.